Canton Strategic Holdings (CNTN) Accumulated Expenses (2020 - 2026)
Canton Strategic Holdings (CNTN) reported Accumulated Expenses of $739033.0 for Q1 2026, down 33.88% on a YoY basis from $1.1 million in Q1 2025, and down 66.35% quarter-over-quarter from $2.2 million in Q4 2025.
Canton Strategic Holdings (CNTN) Accumulated Expenses (2020 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Accumulated Expenses for 7 years, with the latest figure at $739033.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses fell 33.88% year-over-year to $739033.0; the trailing twelve-month figure through Mar 2026 stood at $739033.0 (down 33.88% YoY), and the FY2025 full-year result was $2.2 million, up 65.83% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $739033.0, down from $2.2 million in the prior quarter.
- The five-year high for Accumulated Expenses was $2.2 million in Q4 2025, with the low at $34000.0 in Q1 2022.
- Historically, Accumulated Expenses has averaged $673662.0 across 5 years, with a median of $579462.0 in 2024.
- Annual changes were most pronounced in 2023 — Accumulated Expenses plunged 63.5% — and 2024, when it surged 753.79%.
- Canton Strategic Holdings' Accumulated Expenses stood at $190468.0 in 2022, then soared by 375.92% to $906469.0 in 2023, then jumped by 46.1% to $1.3 million in 2024, then soared by 65.83% to $2.2 million in 2025, then plunged by 66.35% to $739033.0 in 2026.
- The last three Accumulated Expenses figures came in at $739033.0 (Q1 2026), $2.2 million (Q4 2025), and $689804.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 739,033.00 |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | 689,804.00 |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 579,462.00 |
| Mar 31, 2024 | 527,527.00 |
| Dec 31, 2023 | 906,469.00 |
| Sep 30, 2023 | 190,293.00 |
| Jun 30, 2023 | 67,869.00 |
| Mar 31, 2023 | 242,220.00 |
| Dec 31, 2022 | 190,468.00 |
| Sep 30, 2022 | 34,000.00 |
| Jun 30, 2022 | 185,944.00 |
| Mar 31, 2022 | 34,000.00 |
| Dec 31, 2021 | 179,621.00 |
| Dec 31, 2020 | 73,066.00 |